CEL-SCI (CVM) awards CSO Talor Eyal 250,000 stock options

Rhea-AI Filing Summary

CEL-SCI Corp (CVM) reported that Chief Scientific Officer Talor Eyal received a grant of 250,000 options to acquire Common Stock. The options have an exercise price of $1.49 per share, expire on August 13, 2036, and vest in three equal annual installments starting one year after the grant date. Following this award, Eyal directly holds 331,625 options in total.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider TALOR EYAL

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Grant/Award	Options F1	250,000	$0.01	$3K

Holdings After Transaction: Options — 331,625 shares (Direct)

Footnotes (1)

1. F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Key Figures

Options granted: 250,000 options Exercise price: $1.49 per share Grant date option value field: $0.01 per option +3 more

6 metrics

Options granted 250,000 options Grant of options to Chief Scientific Officer Talor Eyal

Exercise price $1.49 per share Exercise price of the newly granted options

Grant date option value field $0.01 per option Transaction price per option reported for the grant

Options after transaction 331,625 options Total options directly held by Talor Eyal following the grant

Expiration date 2036-08-13 Expiration date of the granted options

Underlying shares 250,000 shares Common Stock underlying the newly granted options

Key Terms

Grant, award, or other acquisition, exercise price, vesting, derivative

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

exercise price financial

"conversion_or_exercise_price: 1.4900"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The stock options vest in three (3) equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

derivative financial

"transaction_type: derivative"

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

FAQ

What did CEL-SCI (CVM) disclose about Talor Eyal in this Form 4?

CEL-SCI reported that Chief Scientific Officer Talor Eyal received a grant of 250,000 stock options. These options are for Common Stock and represent an additional equity-based compensation award to the executive.

What are the key terms of Talor Eyal’s new option grant at CEL-SCI (CVM)?

Talor Eyal was granted 250,000 options with an exercise price of $1.49 per share, expiring on August 13, 2036. The options relate to CEL-SCI’s Common Stock and are held directly.

How do Talor Eyal’s options vest according to the CEL-SCI (CVM) Form 4?

The filing states the options vest in three equal annual installments beginning one year after the grant date. This means one-third of the 250,000 options becomes exercisable each year over three years.

What is Talor Eyal’s total option holdings after this transaction at CEL-SCI (CVM)?

After the reported grant, Talor Eyal directly holds 331,625 options in total. This figure includes the newly awarded 250,000 options as part of his overall derivative holdings in CEL-SCI stock.

Was this CEL-SCI (CVM) Form 4 transaction part of a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed for this filing. The acquisition is reported as a grant or award, not as a transaction executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 09:27 AM Accepted by SEC EDGAR 08/17/2026 - 09:27 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TALOR EYAL

(Last) (First) (Middle)

8229 BOONE BLVD

STE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$1.49	08/14/2026		A		250,000		(1)	08/13/2036	Common Stock	250,000	$0.01	331,625	D

Explanation of Responses:

1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

	Eyal Talor	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)